Viewing Study NCT00396968

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 5:50 PM
Ignite Modification Date: 2026-01-27 @ 1:00 AM
Study NCT ID: NCT00396968
Status: WITHDRAWN
Last Update Posted: 2014-02-11
First Post: 2006-11-06
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: AMD3100 With Busulfan, Fludarabine and Thymoglobulin for Allogeneic Stem Cell Transplant for AML and MDS
Sponsor: Genzyme, a Sanofi Company
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Acute Myelogenous Leukemia View
None Myelodysplastic Syndromes View
Keywords:

Keywords

Keyword Brief Keyword Text View
None AMD3100 View
None Acute Myelogenous Leukemai View
None Myelodysplastic Syndromes View
None Allogeneic stem cell transplantation View